Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Regulatory
  • Biopharma industry endorses Pazdur for FDA commissioner role
  • Regulatory

Biopharma industry endorses Pazdur for FDA commissioner role

Pharmaceutical Technology

Hundreds of biopharma leaders say Dr Richard Pazdur has the necessary qualities to lead the FDA amid a crisis of confidence.

Read full story

pharminent May 15, 2026

Pharmaceutical Technology

Hundreds of biopharma leaders say Dr Richard Pazdur has the necessary qualities to lead the FDA amid a crisis of confidence.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: ECO 2026: tirzepatide shows potential for T1D treatment
Next: Lilly UK recruits ex-England cricketer as obesity champion

Related Stories

  • Regulatory

Celcuity gets FDA nod for first-in-class breast cancer drug

pharminent July 15, 2026
  • Regulatory

FDA clears at-home start dose for Alzheimer’s drug Leqembi

pharminent July 14, 2026
  • Regulatory

FDA posts new rejection letters days after confirming pause

pharminent July 13, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.